P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent, cell death

Blood

Volumn 93, Issue 3, 1999, Pages 1075-1085

  Johnstone, Ricky W ^a   Cretney, Erika ^a   Smyth, Mark J ^a  

^a AUSTIN RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; FAS LIGAND; GLYCOPROTEIN P; TUMOR NECROSIS FACTOR;

ARTICLE; CANCER RESISTANCE; CELL DEATH; CELL PROTECTION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0032950954     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.3.1075     Document Type: Article

References (53)

1. Gottesman MM, Pastan I: Biochemistry of multidrug resistance mediated by the multidrug transporter. Ann Rev Biochem 62:385, 1993
2. Dano K: Active outward transport of daunomycin in resistant Erlich ascites tumor cells. Biochim Biophys Acta 323:466, 1973
3. Juliano RL, Ling V: A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455:152, 1976
4. Ueda K, Cardarelli C, Gottesman MM, Pastan I: Expression of a full length cDNA for the human MDR1 gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc Natl Acad Sci USA 84:3004, 1987
5. Higgins CF, Gottesman MM: Is the multidrug transporter a flippase? Trends Biochem Sci 17:18, 1997
6. Van Helvoort A, Smith AJ, Sprong H, Fritzsche I, Schinkle A, Borst P, van Meer G: MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell 87:507, 1996
7. Gill DR, Hyde SC, Higgins CF, Vilvarde MA, Mintenig GM, Sepulveda FV: Separation of drug transport and chloride channel functions of the human multidrug resistance P-glycoprotein. Cell 71:23, 1992
8. Hoffman MM, Roepe PD: Analysis of ion transport pertubations caused by human MDR1 protein overexpression. Biochemistry 36: 11153, 1997
9. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC: Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 84:7735, 1987
10. Thiebaut F, Tsuruo T, Hamada H, Gottesman MM, Pastan I, Willingham MC: Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: Evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein. J Histochem Cytochem 37:159, 1989
11. Cordon-Cardo C, O'Brien JP, Boccia J, Casals D, Bertino JR, Melamed MR: Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J Histochem Cytochem 38:1277, 1990
12. Klimecki WT, Futscher BW, Grogan TM, Dalton WS: P-glycoprotein expression and function in circulating blood cells from normal volunteers. Blood 83:2451, 1994
13. Schinkel AH, Smit JJM, van Tellingen O, Beijnen JH, Wagenaar E, van Deemter L, Mol CM, van der Valk MA, Robanus-Maandag EC, te Riele HPJ, Borst P: Disruption of the mouse mdr 1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell 77:491, 1994
14. Schinkel AH, Mayer U, Wagenaar E, Mol CA, van Deemter L, Smit JJ, van der Valk MA, Voordouw AC, Spits H, van Tellingen O, Zijlmans JM, Fibbe WE, Borst P: Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. Proc Natl Acad Sci USA 98:4028, 1997
15. Kumar S, Lavin MF: The ICE family of cysteine proteases as effectors of cell death. Cell Death Diff 3:255, 1996
16. Nagata S: Apoptosis by death factor. Cell 88:355, 1997
17. Suda T, Takahashi T, Goldstein P, Nagata S: Molecular cloning and expression of the Fas ligand: A novel member of the tumor necrosis factor family. Cell 75:1169, 1993
18. Tartaglia L, Rothe M, Hu YF, Goeddel DV: Tumor necrosis factors cytotoxicity activity is signaled by the p55 TNF receptor. Cell 73:213, 1993
19. Rehemtulla A, Hamilton CA, Chinnaiyan AM, Dixt V: Ultraviolet radiation-induced apoptosis is mediated by activation of CD-95 (Fas/APO-1). J Biol Chem 272:25783, 1997
20. Kasibhatia S, Brunner T, Genetier L, Echeverri F, Mahboubi A, Green DR: DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kB and AP-1. Mol Cell 1:543, 1998
21. Heusel J, Wesselschmidt R, Shresta R, Russell J, Ley T: Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 76:977, 1994
22. Smyth MJ, Trapani JA: Granzymes: Exogenous proteinases that induce target cell apoptosis. Immunol Today 16:202, 1995
23. Robinson LJ, Roberts WK, Ling TT, Lamming D, Sternberg SS, Roepe PD: Human MDR1 protein overexpression delays the apoptotic cascade in Chinese hamster ovary fibroblasts. Biochemistry 36:11169, 1997
24. Sarin A, Williams MS, Alexander-Miller MA, Berzofsky JA, Zacharchuk CM, Henkart PA: Target cell lysis by CTL granule exocytosis is independent of ICE/Ced-3 family proteases. Immunity 6:209, 1997
25. Smyth MJ, Krasovskis E, Sutton VR, Johnstone RW: The drug efflux protein, P-glycoprotein, additionally protects drug-resistant tumor cells from multiple forms of caspase-dependent apoptosis. Proc Natl Acad Sci USA 95: 7024, 1998
26. Zalcberg JR, Hu XF, Wall DM, Mirski S, Cole S, Nadalin G, De Luise M, Parkin JD, Vrazas V, Campbell L, Kantharidis P: Cellular and karyotypic characterization of two doxorubicin resistant cell lines isolated from the same parental human leukemia cell line. Int J Cancer 57:522, 1994
27. Lee CGL, Pastan I, Gottesman MM: Retroviral transfer of human MDR1 gene into human T lymphocytes. Methods Enzymol 292:557, 1996
28. Shi L, Kraut RP, Aebersold R, Greenberg AH: Purification of three cytotoxic lymphocyte granule serine proteases that induce apoptosis through distinct substrate and target cell interactions. J Exp Med 175:553, 1992
29. Gottlieb RA, Nordberg J, Skowronski E, Baboir BM: Apoptosis induced in Jurkat cells by several agents is preceded by intracellular acidification. Proc Natl Acad Sci USA 93:654, 1996
30. Drach J, Gsur A, Hamilton G, Zhao S, Angerler J, Fiegl M, Zojer N, Raderer M, Haberl I, Andreef M, Huber H: Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytes. Blood 88:1747, 1996
31. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X: Cytochrome c and dATP-dependent formation of Apaf-1/caspase 9 complex initiates an apoptotic protease cascade. Cell 91:479, 1997
32. Hamada H, Tsuruo T: Purification of the 170-to 180-kilodalton membrane glycoprotein associated with multidrug resistance. 170-to 180-kilodalton membrane glycoprotein is an ATPase. J Biol Chem 263:1454, 1988
33. Ambudkar SV, Lelong IH, Zhang J, Cardarelli CO, Gottesman MM, Pastan I: Partial purification and reconstitution of the human multidrug-resistance pump: characterization of the drug-stimulatable ATP hydrolysis. Proc Natl Acad Sci USA 89:8472, 1992
34. Broxterman HJ, Pinedo HM, Kuiper CM, Kaptein LCM, Schuurhuis GJ, Lankelma J: Induction by verapamil of a drug increase in ATP consumption in multidrug-resistant tumor cells. FASEB J 2:2278, 1988
35. Thiebaut F, Currier SJ, Whitaker J, Haugland RP, Gottesman MM, Pastan I, Willingham MC: Activity of the multidrug transporter results in alkalinization of the cytosol: Measurement of cytosolic pH by microinjection of a pH-sensitive dye. J Histochem Cytochem 38:685, 1990
36. Li J, Eastman A: Apoptosis in an interleukin-2-dependent cytotoxic T lymphocyte cell line is associated with intracellular acidification. J Biol Chem 270:3203, 1995
37. Mechetner EB, Schott B, Morse BS, Stein WD, Druley T, Davis KA, Tsuro T, Roninson IB: P-glycoprotein function involves conformational transitions detectable by different immunoreactivity. Proc Natl Acad Sci USA 94:12908, 1997
38. Germann UA: P-glycoprotein-a mediator of multidrug resistance in tumor cells. Eur J Cancer 32A:927, 1996
39. Kagi D, Ledermann B, Burki K, Depraetere V, Nagata S, Hengartner H, Golstein P: Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265:528, 1994
40. Smyth MJ, Krasovskis E, Johnstone RW: Fas ligand-mediated lysis of self bystander targets by human papillomavirus-specific CD8 + cytotoxic T lymphocytes. J Virol 72:5948, 1998
41. Ando K, Hiroishi K, Kaneko T, Moriyama T, Muto Y, Kayagaki N, Yagita Y, Okumura K, Imawari M: Perforin, Fas/Fas ligand and TNF-alpha pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL. J Immunol 158:5283, 1997
42. Salmon SE, Soehnlen B, Dalton WS, Meltzer P, Scuderi P: Effects of tumor necrosis factor on sensitive and multidrug resistant human leukemia and myeloma cell lines. Blood 74:1723, 1989
43. Malorni W, Rainaldi G, Tritarelli E, Rivabene R, Cianfriglia M, Lehnert M, Donelli G, Peschele C, Testa U: Tumor necrosis factor alpha is a powerful apoptotic inducer in lymphoid leukemia cells expressing P-170 glycoprotein. Int J Cancer 67:238, 1996
44. Jia L, Kelsey SM, Grahn MF, Jiang X-R, Newland AC: Increased activity and sensitivity of mitochondrial respiratory enzymes to tumor necrosis factor alpha-mediated inhibition is associated with increased cytotoxicity in drug-resistant leukemic cell lines. Blood 87:2401, 1996
45. Bezombes C, Maestre N, Laurent G, Levade T, Bettaieb A, Jaffrezou JP: Restoration of TNF-alpha-induced ceramide generation and apoptosis in resistant human leukemia KG1a cells by the P-glycoprotein blocker PSC833. FASEB J 12:101, 1998
46. Hunnun YA: Apoptosis and the dilemma of cancer chemotherapy. Blood 89:1845, 1997
47. Miyashita T, Reed JC: Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line. Blood 81:151, 1993
48. Schmitt E, Cimoli G, Steyaert A, Bertrand R: Bcl-xL modulates apoptosis induced by anticancer drugs and delays DEVDase and DNA fragmentation-promoting activities. Exp Cell Res 240:107, 1998
49. Friesen C, Herr I, Krammer PH, Debatin K-M: Involvement of the CD95 (Apo-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat Med 2:574, 1996
50. Eischen CM, Kottke TJ, Martins LM, Basi GS, Tung JS, Earnshaw WC, Leibson PJ, Kaufmann SC: Comparison of apoptosis in wild-type and Fas-resistant cells: Chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions. Blood 90:935, 1997
51. Walsh CM, Wen BG, Chinnaiyan AM, O'Rourke K, Dixit VM, Hedrick SM: A role for FADD in T cell activation and development. Immunity 8:439, 1998
52. De Maria R, Lenti L, Malisan F, d'Agostino F, Tomassini B, Zeuner A, Rippo MR, Testi R: Requirement for the GD3 ganglioside in CD95-and ceramide-induced apoptosis. Science 277:1652, 1997
53. Lavoie JN, Nguyen M, Marcellus RC, Branton PE, Shore GC: E4orf4, a novel adenovirus death factor that induces p53-independent apoptosis by a pathway that is not inhibited by zVAD-fmk. J Cell Biol 140:637, 1998